Test 4 Flashcards
Histamine Receptor Antagonist
Benedryl, Atarax, Phenergan(1st Gen), Claritin (2nd Gen))
Antinasuea/antiemetic (Dramamine, Phenergan)
Serotonin Agonist
Buspirione (5-HT 1A)
Sumitriptan/Imitrex (5-HT 1B/1D)
Serotonin Antagonist
Odansetron/Zofran (5-HT3)
Phenoxybenzamine (5-HT2)
Cyproheptadine (5-HT2 and H1)
Chlorpomazine (5-HT2)
Migraine - Preventive Anti-seizure drug
Valproate, Topiramate
MAbs for migrane
Aimovig
Withdrawn Serotonin Weight Loss Drugs
(Dex)Fenfluramine/Fen-phen - 5-HT2 agonist
Lorcaserin – 5-HT2C agonist
Non-serotonin Weight Loss Drugs
Liraglutide – GLP-1 agonist (diabetes)
Orlistat – GI Lipase inhibitor
Dopamine Pathway “Nigrostriatal”
Motor Movement
Dopamine Pathway “Mesolimbic”
Reinforcement and Addiction
Dopamine Pathway “Mesocortical”
Working memory and planning
Serotonin reuptake inhibitors (SSRIs)
Prozac, Zoloft
Selective serotonin-NE reuptake inhibitors (SNRIs)
Pristique, Cymbalta
Tricyclic antidepressants (TCAs)
Elavil
Monoamine oxidase inhibitors (MAOIs)
Nardil
Selegiline
NDRI
Buproprion (Wellbutrin)
Solriamfetol (Sunosi)
Antipsychotics
Major depression (with SSRIs)
Aripiprazole (Abilify)
Amisulpride for Schizophrenia (D2 Receptor antagonist)
Phenytoin (Dilantin)’s plasma Levels
Therapeutic: 10-20 mcg/ml
Free phenytoin: 10% 1-2.5 mcg/ml
Toxic: 30-50 mcg/ml
Lethal: >100 mcg/ml
Phenytoin (Dilantin)
Anti-Seizure
Fosphenytoin (more soluble form), Drug Displacement
Protein bound, accumulation
T1/2 = 12-36 hours
Toxicity: Vision problems (Nystagmus, Loss of extra-ocular pursuit of movement, diplopia), Ataxia and Sedation, Gingival hyperplasia, Hirsutism, Skin problems (Coarsening of facial features, Rash, Skin legions)
Chronic phenytoin use makes it resistant to NMB and can enhance NMB if present in blood.
Carbamazepine (Tegretol)
Anti-Seizure
Peaks 6-8 hr, 70% PP bound, no displacement
T1/2 = 36→20 hr
Toxicity: Diplopia, ataxia, GI, drowsiness
Phenobarbitol
Anti-Seizure
A: 70-90%, 20-45% PP bound
Phase II metabolism
Toxicity: SEDATION, hepatic enzyme inducer
Ethosuximide
Drug of choice for Absense Seizure
Complete A, No fat D, Phase II metabolism, Clearance decreased by Valproic Acid
Toxicity: GI, Lethargy, hiccup, euphoria
Only available as syrup
Valproic Acid (Depakene)
Anti-Seizure
A:80%, 90% PP bound,
T1/2 = 9-18 hr
Toxicity: Hepato, GI, sedation, fine tremor
Displaces phenytoin from proteins making it more toxic
Benzodiazepines
Anti Seizure
T1/2 = 20-50 hr (active met. 50-100 hr); 20-30 minute duration